Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | Linsitinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 3112.00 | 2597.00 | 1.1983 | 1.1623 |
| MDA-MB-231 | Lapatinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2947.00 | 2597.00 | 1.1348 | 1.1121 |
| MDA-MB-231 | Linsitinib | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2828.00 | 2597.00 | 1.0889 | 1.0749 |
| MDA-MB-231 | 17-AAG | 10 | uM | 10 | 1250.00 | 520.59 | 623.00 | 2597.00 | 0.2399 | 0.0805 |
| MDA-MB-231 | Lapatinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2778.00 | 2597.00 | 1.0697 | 1.0590 |
| MDA-MB-231 | 17-AAG | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2555.00 | 2597.00 | 0.9838 | 0.9860 |
| MDA-MB-231 | Linsitinib | 10 | uM | 10 | 1250.00 | 520.59 | 2053.00 | 2597.00 | 0.7905 | 0.8072 |
| MDA-MB-231 | Linsitinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2526.00 | 2597.00 | 0.9727 | 0.9762 |
| MDA-MB-231 | Erlotinib | 0.31623 | uM | 10 | 1250.00 | 520.59 | 2485.00 | 2597.00 | 0.9569 | 0.9623 |
| MDA-MB-231 | Erlotinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 2474.00 | 2597.00 | 0.9526 | 0.9586 |
| MDA-MB-231 | Erlotinib | 1 | uM | 10 | 1250.00 | 520.59 | 2260.00 | 2597.00 | 0.8702 | 0.8836 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2466.00 | 2597.00 | 0.9496 | 0.9559 | |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2466.00 | 2597.00 | 0.9496 | 0.9559 | |
| MDA-MB-231 | Linsitinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 2517.00 | 2597.00 | 0.9692 | 0.9732 |
| MDA-MB-231 | Linsitinib | 0.01 | uM | 10 | 1250.00 | 520.59 | 2797.00 | 2597.00 | 1.0770 | 1.0650 |
| MDA-MB-231 | Erlotinib | 19.9526 | uM | 10 | 1250.00 | 520.59 | 1853.00 | 2597.00 | 0.7135 | 0.7290 |
| MDA-MB-231 | 17-AAG | 0.0016596 | uM | 10 | 1250.00 | 520.59 | 2616.00 | 2597.00 | 1.0073 | 1.0063 |
| MDA-MB-231 | 17-AAG | 1 | uM | 10 | 1250.00 | 520.59 | 1992.00 | 2597.00 | 0.7670 | 0.7838 |
| MDA-MB-231 | Erlotinib | 0.1 | uM | 10 | 1250.00 | 520.59 | 2940.00 | 2597.00 | 1.1321 | 1.1099 |
| MDA-MB-231 | 17-AAG | 0.031623 | uM | 10 | 1250.00 | 520.59 | 2646.00 | 2597.00 | 1.0189 | 1.0162 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 2861.00 | 2597.00 | 1.1017 | 1.0853 | |
| MDA-MB-231 | Lapatinib | 3.1623 | uM | 10 | 1250.00 | 520.59 | 3209.00 | 2597.00 | 1.2357 | 1.1911 |
| MDA-MB-231 | 17-AAG | 0.01 | uM | 10 | 1250.00 | 520.59 | 3198.00 | 2597.00 | 1.2314 | 1.1879 |
| MDA-MB-231 | 0 | uM | 10 | 1250.00 | 520.59 | 3152.00 | 2597.00 | 1.2137 | 1.1742 | |
| MDA-MB-231 | Erlotinib | 10 | uM | 10 | 1250.00 | 520.59 | 2600.00 | 2597.00 | 1.0012 | 1.0010 |